Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Evaluation Review|February 20, 2013
When is a program ready for rigorous impact evaluation? The role of a falsifiable logic modelDiana Epstein, Jacob Alex Klerman
Evaluation Review|June 20, 2012
Independent evaluation: insights from public accountingAbigail B Brown, Jacob Alex Klerman
The American Journal of Case Reports|May 21, 2023
Renovascular Hypertension with Progressive Atherosclerotic Renal Artery Stenosis in an Elderly Patient with Known Fibromuscular Dysplasia: A Case ReportJacob Alex, Dhruv Rajpurohit, Marcel Zughaib
The Journal of Urology|March 27, 2007
Predictors of overall and cancer-free survival of patients with localized prostate cancer treated with primary androgen suppression therapy: results from the prostate cancer outcomes studyJulie N Graff, Motomi Mori, Hong Li, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 23, 2023
Metastatic Hormone-Sensitive Prostate Cancer: Toward an Era of Adaptive and Personalized TreatmentAnis A Hamid, Nicolas Sayegh, Bertrand Tombal, et al.
Science Advances|June 1, 2017
Antibody-mediated neutralization of soluble MIC significantly enhances CTLA4 blockade therapyJingyu Zhang, Dai Liu, Guangfu Li, et al.
Inorganic Chemistry|May 15, 2002
Electrochemistry and photoelectron spectroscopy of oxomolybdenum(V) complexes with phenoxide ligands: effect of para substituents on redox potentials, heterogeneous electron transfer rates, and ionization energiesJulie N Graff, Anne E McElhaney, Partha Basu, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|November 25, 2022
Gender and Patient Satisfaction in a Veterans Health Administration Outpatient Chemotherapy UnitMalinda T West, Gagah P Tamba, Rajat Thawani, et al.
Evaluation Review|November 1, 2022
Using Behavioral Insights to Market a Workplace Safety Program: Evidence From a Multi-Armed ExperimentRandall Juras, Amy Gorman, Jacob Alex Klerman
BJU International|August 3, 2016
Cyclooxygenase-2 (COX-2) inhibition for prostate cancer chemoprevention: double-blind randomised study of pre-prostatectomy celecoxib or placeboJason F Flamiatos, Tomasz M Beer, Julie N Graff, et al.
Pageof 8